Dietary Rehabilitation in Severely Acutely Malnourished Children

NCT ID: NCT05009823

Last Updated: 2023-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1959 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-10

Study Completion Date

2023-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Severe acute malnutrition (SAM) is a life threatening condition and is defined by 1) a weight-for-height Z-score more than three standard deviations (SD) below the median based on the 2006 World Health Organization (WHO) growth standards, 2) a mid-upper arm circumference (MUAC) of less than 115 mm or 3) by the presence of nutritional edema. Signs such as edema, mucocutaneous changes, hepatomegaly, lethargy, anorexia, anemia, severe immune deficiency and rapid progression to mortality characterize a state commonly coined as "complicated SAM". Kwashiorkor is one of the forms of complicated SAM commonly distinguished by the unmistakable presence of bipedal edema. SAM results in high mortality rates of up to half a million child deaths annually. Undernourished children are at higher risk of mortality ranging from three-times more risk among children with moderate malnutrition to 10-times in SAM children compared to well-nourished children. Children with complicated SAM require inpatient treatment in specialized centers.

The "Rehabilitation and Nutritional Education Center" (CREN) is a specialized center in Burkina Faso receiving on average 10 SAM children per day. Recovery rate is lower than international standards; and adverse events and mortality remain strikingly high.

The main objective of this study is to assess the underlying risk factors affecting the effectiveness of the nutritional therapeutic treatment protocol for complicated SAM children under 5 years of age who have been referred to the CREN, at the Centre Hôspitalier Universitaire Souro, Bobo Dioulasso, Burkina Faso.

The specific objective of this study is to better understand underlying risk factors associated with a lower recovery rate and high mortality in complicated SAM children referred to CREN for inpatient care. Risk factors associated with poor response to a standard dietary treatment at any phase will be assessed retrospectively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Severe acute malnutrition (SAM), defined as severe wasting \[weight-to-height Z-score \< -3 standard deviations (SD), based on the WHO Child Growth Standards\] and / or the presence of nutritional edema, and / or mid-upper arm circumference (MUAC) \<115 mm, is a condition that requires urgent attention and appropriate management to reduce mortality and promote recovery among children. Management of SAM children without complications is provided at the community level. Hospitalization in specialized care centers is necessary for SAM children with complications. SAM children with comorbidities have a greater risk of mortality and treatment failure. The knowledge of the specific adequate nutritional needs of SAM is limited.

For the treatment of SAM in hospital, the WHO recommends the use of therapeutic milk low in protein 'F75' in the stabilization phase; and more protein-rich F100 or F75 combined with ready-to-use therapeutic foods (RUTF) in the transition phase. The WHO also recommends using as an alternative formula made of cereal flour, skimmed milk powder, oil, sugar, and a therapeutic vitamin and mineral complex (CMV), in case of shortage of the standard therapeutic milk F75 / F100 or in case of signs of intolerance (vomiting, diarrhea).

The Refeeding Center - Centre de Récupération et d'Education Nutritionnelle (CREN) of the Sourô Sanou University Hospital Center (CHUSS) in Burkina Faso specializes in the care of SAM children with complications. In 2018, out of 500 children aged 6-59 months admitted for SAM with complications, the CHUSS CREN registered 86.8% full recovery, 8.2% dropout and 5% death. Although the recovery rate is higher than international standards (greater than 75%), the mortality rate remains higher than the recommended 3% by international standards; in addition to the challenges that are faced locally in maintaining high standards of care. At the CREN, the investigators and the nurses observed that some SAM children with complications can have severe diarrhea and vomiting after taking F75 (first phase of the nutritional treatment). It was also observed that other SAM children with edema, whose edema resolved in the first phase of treatment under F75, redeveloped edema when they received RUTF (Plumpy Nut®) in the transition phase according to the WHO 2013 protocol.

This research project, which will be subdivided into a retrospective study and two prospective clinical trials aims to assess the risk factors affecting the response to dietary treatment in this center (the CREN, Burkina Faso) and to compare alternatives for treatment during the nutritional rehabilitation.

The retrospective study assesses the factors of failure of dietary treatment in the three phases of nutritional rehabilitation to better understand underlying risk factors associated with a lower recovery rate and high mortality in complicated SAM children referred to CREN for inpatient care. Risk factors associated with poor response to a standard dietary treatment at any phase will be assessed retrospectively and include:

1. Errors in the treatment (feeding) dosage that can be due to errors in anthropometric measurement and/or in reading the feeding regimen table by the CREN team;
2. Low adherence of children to the therapeutic dietary regimen
3. Comorbidities associated with malnutrition that can have an effect on the dietary treatment effectiveness
4. Types of dietary regimen selected during the first phase of treatment \[F75 vs. alternative F75 (cereal flour, oil, sugar, powdered milk) with OR without CMV)\] and during the transition phase \[F75 + RUTF ( Plumpy-Nut®), F100, alternative F75 (with and without CMV) + RUTF (Plumpy Nut®)\].

The study will use data collected during admission and follow-up of SAM children with complications admitted at the CREN of the CHUSS from January 2014 to December 2018.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Acute Malnutrition Kwashiorkor Nutritional Edema Marasmus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stabilization phase

The dietetic treatment is given by the nurses every 2 hours on the first day; then if tolerance is good, every 3 hours the following days. No family meals during the stabilization phase. But the baby can breastfeed.

A child will receive an antibiotic as per the national protocol, malaria treatment if diagnosed with malaria, Vitamin A if symptomatic eye damage, Folic acid in case of anemia, antifungal in case of candidiasis.

Standard F75

Intervention Type DIETARY_SUPPLEMENT

F-75 contains 75 kcal and 0.9 g protein per 100 ml.

Alternative F75 With CMV

Intervention Type DIETARY_SUPPLEMENT

Cereal flour, oil, sugar, powdered milk with complex mineral-vitamin.

Alternative F75 Without CMV

Intervention Type DIETARY_SUPPLEMENT

Cereal flour, oil, sugar, powdered milk without complex mineral-vitamin.

Transition phase

The child is assigned to one the therapeutic regimen depending on the treatment received during the stabilization phase and the results of the appetite test.

F100

Intervention Type DIETARY_SUPPLEMENT

100 kcal and 3 g protein per 100 ml if the test of appetite at the end of the stabilization phase is negative (the child does not accept the Plumpynut)

Standard F75 + RUTF

Intervention Type DIETARY_SUPPLEMENT

Standard F75 with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive

Alternative F75 with CMV + RUTF

Intervention Type DIETARY_SUPPLEMENT

Alternative F75 + CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 + CMV during the stabilization phase

Alternative F75 without CMV + RUTF

Intervention Type DIETARY_SUPPLEMENT

Alternative F75 - CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 - CMV during the stabilization phase

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard F75

F-75 contains 75 kcal and 0.9 g protein per 100 ml.

Intervention Type DIETARY_SUPPLEMENT

Alternative F75 With CMV

Cereal flour, oil, sugar, powdered milk with complex mineral-vitamin.

Intervention Type DIETARY_SUPPLEMENT

Alternative F75 Without CMV

Cereal flour, oil, sugar, powdered milk without complex mineral-vitamin.

Intervention Type DIETARY_SUPPLEMENT

F100

100 kcal and 3 g protein per 100 ml if the test of appetite at the end of the stabilization phase is negative (the child does not accept the Plumpynut)

Intervention Type DIETARY_SUPPLEMENT

Standard F75 + RUTF

Standard F75 with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive

Intervention Type DIETARY_SUPPLEMENT

Alternative F75 with CMV + RUTF

Alternative F75 + CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 + CMV during the stabilization phase

Intervention Type DIETARY_SUPPLEMENT

Alternative F75 without CMV + RUTF

Alternative F75 - CMV with ready to-use therapeutic food (Plumpynut) if the test of appetite at the end of the stabilization phase is positive and the child received Alternative F75 - CMV during the stabilization phase

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Severe acute malnutrition defined as Weight-for-Height Z-score (WHZ) \<- 3 SD AND / OR MUAC \<115 mm AND / OR with edema
* With complications
* Who were admitted and treated in the refeeding center (CREN) of the CHUSS from January 2014 TO December 2018
* Aged between 0 and 59 Months

Exclusion Criteria

* Older than 59 Months
* Moderate Acute Malnutrition (MAM)
Minimum Eligible Age

0 Months

Maximum Eligible Age

59 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

Sponsor Role collaborator

University Hospital Sourô Sanou of Bobo Dioulasso (Burkina Faso)

UNKNOWN

Sponsor Role collaborator

Centre Muraz

OTHER

Sponsor Role collaborator

University Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefaan De Henauw, Md. PhD

Role: PRINCIPAL_INVESTIGATOR

University Ghent

Souheila Abbeddou, MSc. PhD

Role: PRINCIPAL_INVESTIGATOR

University Ghent

Jerome Some, Md. PhD

Role: PRINCIPAL_INVESTIGATOR

Institut de Recherche en Sciences de la Sante, Burkina Faso

Bintou Sanogo, MSc. Md.

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire Souro, Bobo Dioulasso, Burkina Faso.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire Souro

Bobo-Dioulasso, , Burkina Faso

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Burkina Faso

References

Explore related publications, articles, or registry entries linked to this study.

Baraki AG, Akalu TY, Wolde HF, Takele WW, Mamo WN, Derseh B, Desyibelew HD, Dadi AF. Time to recovery from severe acute malnutrition and its predictors: a multicentre retrospective follow-up study in Amhara region, north-west Ethiopia. BMJ Open. 2020 Feb 13;10(2):e034583. doi: 10.1136/bmjopen-2019-034583.

Reference Type BACKGROUND
PMID: 32060161 (View on PubMed)

Bartz S, Mody A, Hornik C, Bain J, Muehlbauer M, Kiyimba T, Kiboneka E, Stevens R, Bartlett J, St Peter JV, Newgard CB, Freemark M. Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. J Clin Endocrinol Metab. 2014 Jun;99(6):2128-37. doi: 10.1210/jc.2013-4018. Epub 2014 Feb 27.

Reference Type BACKGROUND
PMID: 24606092 (View on PubMed)

Deen JL, Funk M, Guevara VC, Saloojee H, Doe JY, Palmer A, Weber MW. Implementation of WHO guidelines on management of severe malnutrition in hospitals in Africa. Bull World Health Organ. 2003;81(4):237-43. Epub 2003 May 16.

Reference Type BACKGROUND
PMID: 12764489 (View on PubMed)

Munthali T, Jacobs C, Sitali L, Dambe R, Michelo C. Mortality and morbidity patterns in under-five children with severe acute malnutrition (SAM) in Zambia: a five-year retrospective review of hospital-based records (2009-2013). Arch Public Health. 2015 May 1;73(1):23. doi: 10.1186/s13690-015-0072-1. eCollection 2015.

Reference Type BACKGROUND
PMID: 25937927 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.who.int/publications/i/item/9789241506328

World Health Organization (2013) WHO guideline: updates on the management of severe acute malnutrition in infants and children.

https://www.unicef.fr/article/malnutrition-la-situation-au-burkina-faso

Enquête Nutritionnelle Nationale SMART 2016 au Burkina Faso. 2016 ; 47p.

https://www.humanitarianresponse.info/sites/www.humanitarianresponse.info/files/documents/files/protocole_pcima_bf_janv_2015.pdf

10\. Ministère de la Sante au Burkina Faso. Protocol National : Prise en charge intégrée de la malnutrition aigüe (PCIMA). 2014

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BC-09443

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Screening for Acute Malnutrition
NCT05284773 WITHDRAWN NA